This is a basic article for medical students and other non-radiologists
Intracranial tumours comprise a heterogeneous group of tumours. In adult patients, the majority represent metastatic disease with a smaller proportion being primary brain tumours. Metastasis to the brain occurs, most commonly, from lung, breast, melanoma, renal cell, and colorectal cancers.
On this page:
Reference article
This is a summary article; read more in our article on intracranial tumours.
Summary
-
epidemiology
incidence increases with age
equivocal gender distribution
-
risk factors
malignancy elsewhere
-
presentation
headache
-
features of raised intracranial pressure
nausea & vomiting worse in the morning or positional
altered mental state
focal neurology may occur as the tumour grows
adult-onset seizures
-
incidental finding
some tumours may not cause symptoms
patients may be imaged for another reason, e.g. trauma
-
pathophysiology
-
heterogeneous group of tumours
metastases, e.g. lung, breast, renal
meningiomas
primary parenchymal tumours
pituitary or pineal tumours
cranial nerve schwannomas
tumours are graded using the WHO grade
-
-
investigation
CT is often the first test performed to assess presenting symptoms
MRI may be used with symptoms of headaches or seizures
MRI is the investigation of choice to characterise the tumour
-
treatment
parenchymal brain tumours generally have a poor prognosis
-
treatment should be in specialist centres
steroids may alleviate symptoms caused by oedema
antiseizure medications may help for those with seizures
a biopsy may be performed neurosurgically
some tumours may be removed, e.g. pituitary tumours
stereotactic radiotherapy can be used for small lesions
Imaging
-
role of imaging
confirm intracranial abnormality and prioritise MRI
tumour characterisation
help to determine the grade, and make a decision about biopsy
follow up
-
radiographic features
-
CT
often the first line test
variety of appearances depending on the tumour
hypo- or hyperdense, irregular, well-defined, peripheral or deep
useful to determine oedema and mass effect
contrast may make lesions more conspicuous
CT is especially helpful for determining bony involvement
-
MRI
investigation of choice
fantastic contrast and spatial resolution
origin of tumours can be determined
different sequences are used to determine the likely diagnosis
specialised sequences can be useful to look at tumour metabolites
-